AMETEK Q1 Earnings Surpass Expectations, Revenues Decline Y/Y

01.05.25 16:55 Uhr

Werte in diesem Artikel
Aktien

146,38 EUR -0,08 EUR -0,05%

Indizes

1.854,4 PKT -8,4 PKT -0,45%

5.686,7 PKT 82,5 PKT 1,47%

AMETEK, Inc. AME reported first-quarter 2025 non-GAAP earnings of $1.75 per share, beating the Zacks Consensus Estimate by 3.6%. The figure increased 7% year over year.AMETEK’s top line of $1.73 billion missed the Zacks Consensus Estimate by 0.51%. The figure decreased 0.2% year over year.The company experienced declining sales in its largest EIG segment, partially offset by the year-over-year improvement in the EMG segment. The stock gained 3.8% in the past year, outperforming the Zacks Electronics - Testing Equipment industry’s decline of 3.5%.AMETEK, Inc. Price, Consensus and EPS Surprise AMETEK, Inc. price-consensus-eps-surprise-chart | AMETEK, Inc. QuoteAmetek’s Q1 2025 DetailsEIG sales (65.9% of total revenue) in the first quarter were $1.14 billion, down 1% from the year-ago quarter’s reported figure. The figure missed the Zacks Consensus Estimate of $1.15 billion.In the first quarter, revenues from EMG (34.1% of total revenues) were $588.3 million, up 2% from the year-ago quarter. The figure beat the consensus mark of $580 million.For the first quarter, operating income increased 2% year over year to $454.8 million and operating margin expanded by 60 basis points (bps) from the year-ago quarter.EIG’s operating income in the quarter increased 0.3% to $354.1 million with operating income margins of 31%, reflecting an increase of 50 bps from the year-ago reported figure.EMG's first-quarter operating income was $128.7 million and operating income margins were 21.9% in the quarter. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)AME’s Balance Sheet & Cash FlowAs of March 31, 2025, AME had cash and cash equivalents of $399 million compared with the previous quarter’s $373.9 million.As of March 31, 2025, AME’s long-term debt was $1.46 billion from the previous quarter’s levels.Operating cash flow in the first quarter was $417.5 million, free cash flow was $394.5 million and free cash flow to net income conversion was 112%.AME Updates GuidanceFor 2025, AME still expects overall sales to be up in low single digits on a percentage basis compared to the 2024 reported level. The Zacks Consensus Estimate is pegged at $7.17 billion, indicating a year-over-year increase of 3.4%.The company reiterated its guidance for adjusted earnings per share in the range of $7.02-$7.18, suggesting an increase of 3-5%. The Zacks Consensus Estimate for earnings is pegged at $7.13 per share, indicating a year-over-year increase of 4.4%.Zacks Rank and Stocks to ConsiderCurrently, AME carries a Zacks Rank #3 (Hold).Affirm AFRM, Super Micro Computer SMCI and Paycom Software PAYC are some better-ranked stocks that investors can consider in the broader Zacks Computer & Technology sector. AFRM, SMCI and PAYC sport a Zacks Rank #1 (Strong Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.AFRM shares have gained 4% in the past year. The Zacks Consensus Estimate for AFRM’s 2025 is pegged at a loss of 6 cents per share, narrowed by 7 cents over the past 60 days, suggesting growth of 96.7% from the year-ago quarter’s reported figure.SMCI shares have plunged 56.4% in the past year. The Zacks Consensus Estimate for SMCI’s fiscal 2025 earnings has been revised downward to $2.52 in the past seven days, suggesting year-over-year growth of 14%.PAYC shares have gained 6% over the past year. The Zacks Consensus Estimate for PAYC’s 2025 earnings is pegged at $8.72 per share, implying a rise of 6.21% from the year-ago quarter’s levels.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AMETEK, Inc. (AME): Free Stock Analysis Report Super Micro Computer, Inc. (SMCI): Free Stock Analysis Report Paycom Software, Inc. (PAYC): Free Stock Analysis Report Affirm Holdings, Inc. (AFRM): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Ametek und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Ametek

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ametek

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Ametek Inc.

Wer­bung

Analysen zu Ametek Inc.

DatumRatingAnalyst
04.08.2017Ametek OutperformBMO Capital Markets
08.06.2017Ametek BuyStifel, Nicolaus & Co., Inc.
08.02.2017Ametek OutperformRBC Capital Markets
22.12.2016Ametek OutperformRobert W. Baird & Co. Incorporated
02.11.2016Ametek OutperformRBC Capital Markets
DatumRatingAnalyst
04.08.2017Ametek OutperformBMO Capital Markets
08.06.2017Ametek BuyStifel, Nicolaus & Co., Inc.
08.02.2017Ametek OutperformRBC Capital Markets
22.12.2016Ametek OutperformRobert W. Baird & Co. Incorporated
02.11.2016Ametek OutperformRBC Capital Markets
DatumRatingAnalyst
29.04.2016Ametek NeutralRobert W. Baird & Co. Incorporated
31.10.2012Ametek neutralUBS AG
13.02.2012Ametek neutralUBS AG
31.01.2012Ametek neutralUBS AG
19.09.2011Ametek neutralUBS AG
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ametek Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen